Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA approves new AI-enabled wearable cardioverter defibrillator
The newly approved device can be worn for up to a week at a time, with no daily maintenance required, and includes advanced AI algorithms that minimize the risk of false alarms or inappropriate shocks.
Cardiologists share late-breaking TAVR data on first day of SCAI 2025
New TAVR data on SAPT vs. DAPT and prosthesis-patient mismatch among women were some of the many highlights of the conference's opening day.
Latest EARLY TAVR data suggest it is time to update industry guidelines
Philippe Genereux, MD, principal investigator of EARLY TAVR, presented new data at ACC.25 showing intervening early on crossover patients with asymptomatic severe aortic stenosis led to better outcomes and a reduced stroke rate.
A victory for early treatment: FDA approves first TAVR valves for asymptomatic severe aortic stenosis
The FDA has approved the balloon-expandable Sapien 3 TAVR platform from Edwards Lifesciences for treating asymptomatic severe aortic stenosis. This is the first time the agency has approved any TAVR technology to be used in asymptomatic patients.
Focal ablation yields lower treatment failure rates than surgery for prostate cancer
This is the first randomized controlled trial to compare the use of ultrasound energy-based focal ablation to robot-assisted radical prostatectomy.

Links to all the American College of Cardiology late-breaking studies for ACC.23

Here are links to more information on every late-breaking presentation at ACC.23.

ACC 2023 program chair Douglas Drachman, MD, explains the top takeaways from the American College of Cardiology meeting. #ACC #ACC23

Key takeaways from the ACC 2023 annual meeting

ACC.23 Program Chair Doug Drachman, MD, explains what he saw as some of the key takeaways from the American College of Cardiology (ACC) 2023 annual meeting.

Vaccinated patients more likely to exhibit normal chest CT after COVID infection

Both vaccine status and variant type were shown to be associated with differing COVID severity and chest CT patterns.

Valentin Fuster, MD, PhD, director of Mount Sinai Heart and general director of the Spanish National Center for Cardiovascular Research

High dosage of blood thinners lowers 30-day morbidity for hospitalized COVID-19 patients

For patients who were hospitalized, but not yet in the ICU, those randomly assigned a higher-dose of anticoagulants had lower 30-day mortality risk than those on a lower dose.

COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology

Heart inflammation remains 2 months later in some patients with COVID-19 vaccine-related myocarditis

A team of cardiologists and radiologists collaborated on the study, using advanced imaging to take a closer look at the long-term impact of vaccination.

Poor mental health leads to higher CVD risk in young adults

Even among people who do not experience any major cardiovascular events, researchers noted, there are strong associations between poor mental health and poor heart health.

What new data tell us about TAVR in women with a history of early menopause

Researchers examined data from more than 700 TAVR patients, publishing their findings in the American Journal of Cardiology.

More financial challenges ahead for not-for-profit hospitals

"Margins are not expected to return to pre-pandemic levels for quite some time," according to a new report.

Clinical

FDA approves new AI-enabled wearable cardioverter defibrillator

Cardiologists share late-breaking TAVR data on first day of SCAI 2025

Latest EARLY TAVR data suggest it is time to update industry guidelines

A victory for early treatment: FDA approves first TAVR valves for asymptomatic severe aortic stenosis

Focal ablation yields lower treatment failure rates than surgery for prostate cancer